CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,808,000 | -71.5% | 193,712 | -79.3% | 0.10% | -85.8% |
| Q4 2018 | $16,841,000 | -80.5% | 937,676 | -68.1% | 0.67% | -41.1% |
| Q3 2018 | $86,433,000 | -37.6% | 2,942,904 | -3.4% | 1.14% | -27.4% |
| Q2 2018 | $138,493,000 | +3.2% | 3,045,810 | +19.8% | 1.57% | +7.3% |
| Q1 2018 | $134,224,000 | -32.1% | 2,542,123 | -12.5% | 1.46% | -23.9% |
| Q4 2017 | $197,666,000 | +1.4% | 2,906,849 | +22.8% | 1.92% | +15.9% |
| Q3 2017 | $194,995,000 | +4.4% | 2,366,449 | +18.6% | 1.66% | -18.3% |
| Q2 2017 | $186,805,000 | +44.8% | 1,995,139 | -1.5% | 2.03% | +50.8% |
| Q1 2017 | $128,998,000 | -8.4% | 2,026,045 | -36.1% | 1.34% | -33.6% |
| Q4 2016 | $140,899,000 | +39.3% | 3,171,978 | +13.1% | 2.03% | +94.2% |
| Q3 2016 | $101,112,000 | +230.7% | 2,804,764 | +25.9% | 1.04% | +65.7% |
| Q2 2016 | $30,575,000 | -55.7% | 2,228,524 | -38.0% | 0.63% | -66.1% |
| Q1 2016 | $69,047,000 | -43.7% | 3,596,180 | +2.6% | 1.86% | -40.3% |
| Q4 2015 | $122,637,000 | +2567.2% | 3,503,900 | +6907.8% | 3.12% | +2316.3% |
| Q3 2015 | $4,598,000 | -79.5% | 50,000 | -80.4% | 0.13% | -50.8% |
| Q2 2015 | $22,409,000 | +50.9% | 255,000 | +27.5% | 0.26% | +30.3% |
| Q1 2015 | $14,846,000 | +616.9% | 200,000 | +300.0% | 0.20% | +673.1% |
| Q2 2014 | $2,071,000 | -77.0% | 50,000 | -61.5% | 0.03% | -81.8% |
| Q1 2014 | $9,005,000 | +99.2% | 130,000 | +73.3% | 0.14% | +150.9% |
| Q4 2013 | $4,520,000 | +14.4% | 75,000 | +15.4% | 0.06% | -16.2% |
| Q3 2013 | $3,952,000 | – | 65,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |